|
|
Endacea Home Page
Description: Endacea is a development stage biopharmaceutical company with a proprietary A1 adenosine receptor based technology platform for the treatment of asthma, ischemia-reperfusion organ injury, and Gram-negative septicemia (endotoxemia), as well as an assay for endotoxin.
Keywords: adenosine, A1AR, inflammation, anti-inflammatory, endotoxin, endotoxemia, septicemia, sepsis, asthma, ischemia, reperfusion, ischemia-reperfusion, P2x, purinoceptor, Gram-negative, fibrosis, sclerosis, myocardial, infarction, purine, COPD, autoimmune
Tags:
endotoxin,
endacea,
home,
page,
contact,
science,
company,
careers,
sepsis,
reperfusion,
ischemia,
renal,
impairment,
asthma,
adenosine,
including,
drug,
septicemia,
endotoxemia,
negative,
gram,
inflammation,
anti,
biopharmaceutical,
proprietary,
receptor,
acute,
developing,
biomarker,
candidate,
antagonists,
patents,
antagonist,
methods,
use,
sclerosis,
purinoceptor,
inflammatory,
fibrosis,
purine,
Endotoxin.org
Content Revalency:
Title: 66.67%
Description: 21.21%
Keywords: 20.00% | Document size: 9,039 bytes
More info:
Whois -
Trace Route -
RBL Check
| ENDOTOXIN.ORG - Site Location |
| Country/Flag |
 United States |
| City/Region/Zip Code |
Jacksonville, FL, 32258 |
| Organization |
Defense.Net |
| Internet Service Provider |
MonsterCommerce, LLC |
|
ENDOTOXIN.ORG - Domain Information |
| Domain |
ENDOTOXIN.ORG
[ Traceroute RBL/DNSBL lookup ] |
| Registrar |
Soluciones Corporativas IP, SLU (R1795-LROR)
|
| Whois server |
whois.pir.org |
| Created |
12-Dec-2012 |
| Updated |
29-Nov-2013 |
| Expires |
12-Dec-2014 |
| Time Left |
0 days 0 hours 0 minutes |
| Status |
TRANSFER PROHIBITED
|
| DNS servers |
NS1.ENDOTOXIN.ORG
NS1.ENDOTOXIN.ORG
NS2.ENDOTOXIN.ORG 37.152.88.37
|
| Site Response Header |
| Response |
HTTP/1.1 200 OK |
| Server |
Apache/2.2.14 (Unix) FrontPage/5.0.2.2635 |
| Date |
Mon, 11 Apr 2011 06:28:00 GMT |
| Content-Type |
text/html |
|
